The Use of Dermoscopy in the Delineation of Basal Cell Carcinoma for Mohs Micrographic Surgery: a Systematic Review With Meta-Analysis.
Mohs micrographic surgery
Slow Mohs
basal cell carcinoma
dermatoscopy
dermoscopy
Journal
Dermatology practical & conceptual
ISSN: 2160-9381
Titre abrégé: Dermatol Pract Concept
Pays: Austria
ID NLM: 101585990
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
18
02
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
20
12
2022
Statut:
epublish
Résumé
Several studies investigated the use of dermoscopy in the delineation of basal cell carcinoma (BCC) for Mohs micrographic surgery (MMS) with conflicting results. The purpose of this systematic review with meta-analysis was to evaluate the effectiveness of the use of dermoscopy-guided MMS in the treatment of BCC. We included all comparative studies. Cases of BCC treated using dermoscopy-guided MMS (or slow MMS) were compared to those treated with curettage-guided MMS or "standard" MMS. A total of 6 studies including 508 BCCs were reviewed. There was no statistically significant difference in the proportion of total margin clearance on the first MMS stage between BCCs removed using dermoscopy-guided MMS and those that had curettage or visual inspection. However, lateral margin involvement was significantly lower in BCCs that had dermoscopy-guided MMS. Dermoscopy allows visualization of structures up to 1mm into the dermis. Therefore, it is rational to use it for lateral margin evaluation. Currently, there are two comparative studies showing the efficacy of dermoscopy for lateral margin evaluation during MMS. Future studies are required to develop an evidence-based recommendation regarding the utility of dermoscopy in MMS.
Identifiants
pubmed: 36534540
doi: 10.5826/dpc.1204a176
pii: dp1204a176
pmc: PMC9681184
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e2022176Informations de copyright
©2022 Litaiem N et al.
Déclaration de conflit d'intérêts
Competing interests: None.
Références
Dermatol Surg. 2009 Dec;35(12):2031-5
pubmed: 19758353
JAMA Dermatol. 2015 Oct;151(10):1081-6
pubmed: 25928283
Dermatol Ther. 2022 Apr;35(4):e15333
pubmed: 35080119
Dermatol Surg. 2017 Dec;43(12):1411-1417
pubmed: 28858922
An Bras Dermatol. 2014 Jan-Feb;89(1):38-43
pubmed: 24626646
J Am Acad Dermatol. 2019 Feb;80(2):321-339
pubmed: 29782901
Dermatol Surg. 2012 Jul;38(7 Pt 1):1066-9
pubmed: 22676346
Int J Dermatol. 2017 Jun;56(6):e136-e139
pubmed: 28247925
Dermatol Surg. 2010 Aug;36(8):1240-4
pubmed: 20666811
Dermatol Surg. 2020 Dec;46(12):1473-1480
pubmed: 32149872
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
Adv Biomed Res. 2013 Mar 06;2:2
pubmed: 23930247
Control Clin Trials. 1996 Feb;17(1):1-12
pubmed: 8721797
Int J Dermatol. 2022 Apr;61(4):e139-e141
pubmed: 34013989
Comput Aided Surg. 2014;19(1-3):1-12
pubmed: 24784842
J Invest Dermatol. 2016 Apr;136(4):e33-e38
pubmed: 27012561
Dermatol Ther. 2020 Nov;33(6):e14196
pubmed: 32798257
J Dermatolog Treat. 2022 Feb;33(1):433-436
pubmed: 32345116
Diagnostics (Basel). 2021 Jan 14;11(1):
pubmed: 33466602
Br J Dermatol. 2018 Feb;178(2):565-566
pubmed: 28851098
Dermatol Surg. 2014 Mar;40(3):334-7
pubmed: 24447179